Trial intelligence / Profile preview

Magnesium Sulfate in Severe Preeclampsia

NCT03891498Unknown

Sponsor
Cairo University
Start
Mar 2019
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of magnesium sulfate in preeclampsia, sponsored by Cairo University. Primary endpoint: Uterine Artery Resistance Index at 15 minutes. Status: unknown.

02

Drugs

magnesium sulfate
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT03891498.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03891498.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call